The high glucose-induced stimulation of B1R and B2R expression via CB(1)R activation is involved in rat podocyte apoptosis

Life Sci. 2012 Nov 2;91(19-20):895-906. doi: 10.1016/j.lfs.2012.07.020. Epub 2012 Jul 31.

Abstract

Aims: We examined renal kallikrein-kinin system (KKS) apoptosis and its related signaling pathway in rat podocytes. In addition, we studied the relationship of cannabinoid receptor 1 (CB(1)R) with high glucose and BK receptors.

Main methods: Cell viability was determined by an MTT assay and apoptosis by DNA fragmentation assay, while gene expression was investigated by RT-PCR. Protein expression was analyzed by Western blot analysis. A chemical inhibitor or siRNA transfection was used to inhibit B1R, B2R, and CB(1)R signaling.

Key findings: High glucose (25 mM) treatment decreased cell viability and increased DNA fragmentation. High glucose-induced DNA fragmentation and PARP and caspase-3 activations were blocked by both [des-Arg(10)]-HOE 140 (a B1R antagonist) and HOE 140 (a B2R antagonist). High glucose also increased Akt phosphorylation, ER stress-related protein expression, and NF-κB/I-κB phosphorylation in podocytes, which was blocked by both [des-Arg(10)]-HOE 140 and HOE 140. In addition, B1R and B2R siRNA transfections prevented high glucose-induced Akt and NF-κB activations in rat podocytes. Moreover, AM251 (a CB(1)R antagonist) treatment and CB(1)R siRNA transfection blocked the high glucose-induced stimulation of BK receptor expression, Akt activation, and NF-κB activation.

Significance: Our study suggests that hyperglycemia induces apoptosis via the stimulation of B1R and B2R expression through CB(1)R activation in rat podocytes in vitro, which is associated with the development of diabetic nephropathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis*
  • Bradykinin / analogs & derivatives
  • Bradykinin / pharmacology
  • Cell Survival
  • DNA Fragmentation
  • Endoplasmic Reticulum Stress
  • Gene Expression Regulation
  • Glucose / administration & dosage*
  • Hyperglycemia / physiopathology
  • Kallikrein-Kinin System
  • Piperidines / pharmacology
  • Podocytes / metabolism
  • Pyrazoles / pharmacology
  • Rats
  • Receptor, Bradykinin B1 / genetics*
  • Receptor, Bradykinin B2 / genetics*
  • Receptor, Cannabinoid, CB1 / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tetrahydroisoquinolines / pharmacology

Substances

  • Piperidines
  • Pyrazoles
  • Receptor, Bradykinin B1
  • Receptor, Bradykinin B2
  • Receptor, Cannabinoid, CB1
  • Tetrahydroisoquinolines
  • HOE 140, desArg(10)-
  • AM 251
  • icatibant
  • Glucose
  • Bradykinin